Clinical Trials Directory

Trials / Completed

CompletedNCT01645358

Helmet Ventilation in Acute Hypercapnic Respiratory Failure

Hypercapnic Acute Respiratory Failure: Is the Helmet an Effective Interface?"

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lack of tolerance to the treatment, makes the interface choice for non-invasive ventilation (NIV) one of the key factor. To date the helmet is rarely used in Acute Hypercapnic Respiratory Failure (AHRF), because of its large dead space, despite in hypoxic respiratory failure, it is largely employed as a "rotating" strategy when the facial mask is poorly tolerated. In a multicenter randomized controlled trial, the investigators will compare the clinical efficacy of a new helmet designed to specifically improve the performance in chronic obstructive pulmonary disease (COPD) versus a full face mask during an episode of AHRF.

Conditions

Interventions

TypeNameDescription
DEVICEHelmet (Starmed)The helmet is a kind of interface similar to a hood to deliver NIV
DEVICETotal Face mask (Respironics)The total face mask is the "classical" interface for NIV delivery

Timeline

Start date
2012-07-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2012-07-20
Last updated
2014-10-07

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01645358. Inclusion in this directory is not an endorsement.